Australia's largest stock trading and investment forum Australia's #1 stock forum

VIV

0.00%

2.5¢ vivid technology limited

Its product is demonstrably proven in Australia. Are VIV...

First 33 Last

Share
Profile

Follow
sapporo

1,456 Posts.

1323

14/07/18

19:43

Post #: 34347966
Share

Originally posted by verce ↑

https://www.navigantresearch.com/ne...vice-is-expected-to-reach-2-6-billion-by-2026

According to a new report from Navigant Research, global revenue for lighting as a service (LaaS) in commercial buildings is expected to grow from $663 million in 2017 to $2.6 billion by 2026, a compound annual growth rate of 16.6 percent.

As more lighting products (especially LEDs) and advanced controls come onto the market, and as the internet of things (IoT) continues to expand, the popularity of LaaS is expected to grow, as more and more customers seek the convenience of a third party in managing all aspects of their lighting systems.

According to the report, this shift in business spending is the beginning of a trend that is anticipated to become more common over the next 10 years. Additional market growth is expected to be driven by a maturing LED market, interest in the Internet of Things (IoT) applications, and increases to the bottom line.

According to another report from Zion Market Research ("Lighting as a Service: Global Industry Analysis, Size, Share, Growth, Trends and Forecasts 2016–2024"), the growing demand for energy-efficient lighting is expected to augment the growth of LaaS. In addition, there are government guidelines and regulations for the implementation of energy-efficient lighting systems.

Expand

Its product is demonstrably proven in Australia. Are VIV management capable of cracking the US market is the only question I keep asking myself? Till then, I'm here for the Israeli tech which is the sleeper at the moment.

Gltah

VIV Price at posting: 5.4¢ Sentiment: Buy Disclosure: Held
6 Upvote

0 Great analysis

Reply

Top Stories

BUX

Buxton projects new graphite province discovery at WA Narryer play

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

There are more pages in this discussion • 29 more messages in this thread...

First 33 Last

Add VIV (ASX) to my watchlist

Its product is demonstrably proven in Australia. Are VIV...

Top Stories

Buxton projects new graphite province discovery at WA Narryer play

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

BCI reaches close of funding facility for salt-first part of Mardie project

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Featured News